Significados de malignant neoplasm of lateral floor of mouth en inglés

Background: Histopathologic grading and clinical staging cannot provide a precise prognosis of oral cavity cancer patients.

Conclusions: The prognosis of oral cavity cancer has improved significantly from the early 1970s to recent years.

However, guidelines for the treatment of most forms of HNSCC do not exist in German-speaking countries with the exception of oral cavity cancer.

The objective of this study was to determine the efficacy of paclitaxel and PKI166, a novel inhibitor of EGFR, against oral cavity cancer.

We aimed to evaluate temporal trends in demographics, treatment, and prognosis of oral cavity cancer diagnosed between 1973 and 2014 inclusive.